Defining the risk of involvement for each neck nodal level in patients with early T-stage node-positive oropharyngeal carcinoma.

[1]  Clifton D Fuller,et al.  Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.

[2]  G. Sanguineti,et al.  Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. , 2008, International journal of radiation oncology, biology, physics.

[3]  G. Sanguineti,et al.  A Dosimetric Study Comparing Different Strategies to De-escalate the Dose for Tonsillar Cancer , 2008 .

[4]  C. Grau,et al.  Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study , 2008, Head & neck.

[5]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[6]  Avraham Eisbruch,et al.  Reducing xerostomia by IMRT: what may, and may not, be achieved. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. V. van Engelshoven,et al.  Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. , 2007, European journal of radiology.

[8]  V. Grégoire,et al.  Anatomical bases for the radiological delineation of lymph node areas. Major collecting trunks, head and neck. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  W. Oyen,et al.  18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients , 2007, Journal of Nuclear Medicine.

[10]  A. Garden,et al.  Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. , 2007, International journal of radiation oncology, biology, physics.

[11]  M. Gillison.  Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Buatti,et al.  Changing Failure Patterns in Oropharyngeal Squamous Cell Carcinoma Treated With Intensity Modulated Radiotherapy and Implications for Future Research , 2006, American journal of clinical oncology.

[13]  E. Choi,et al.  Level V Lymph Node Dissection in Oral and Oropharyngeal Carcinoma Patients with Clinically Node‐Positive Neck: Is it Absolutely Necessary? , 2006, The Laryngoscope.

[14]  Margie Hunt,et al.  Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. , 2006, International journal of radiation oncology, biology, physics.

[15]  J. Shah,et al.  Prevalence of lymph nodes in the apex of level V: A plea against the necessity to dissect the apex of level V in mucosal head and neck cancer , 2005, Head & neck.

[16]  J. Califano,et al.  Neck Dissection followed by Radiotherapy or Chemoradiotherapy for Small Primary Oropharynx Carcinoma with Cervical Metastasis , 2005, The Laryngoscope.

[17]  V. Grégoire,et al.  Intensity modulated radiation therapy in head and neck squamous cell carcinoma: state of the art and future challenges. , 2005, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[18]  G. Sanguineti,et al.  Is it feasible to spare part of the mucosa with IMRT and does it matter , 2004 .

[19]  G. Sanguineti,et al.  Are neck nodal volumes drawn on CT slices covered by standard three-field technique? , 2004, International journal of radiation oncology, biology, physics.

[20]  Adam S Garden,et al.  Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. , 2004, Seminars in radiation oncology.

[21]  James F Dempsey,et al.  Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. , 2002, International journal of radiation oncology, biology, physics.

[22]  V Grégoire,et al.  Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  K. Robbins,et al.  Classification of neck dissection: current concepts and future considerations. , 1998, Otolaryngologic clinics of North America.

[24]  B J McNeil,et al.  Comparison of CT and MR Imaging in Staging of Neck , 2005 .

[25]  J. Shah,et al.  Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx , 1990, Head & neck.

[26]  R. Million,et al.  Management of Head and Neck Cancer: A Multidisciplinary Approach , 1984 .

[27]  R. Lindberg.  Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts , 1972, Cancer.

[28]  H. Rouvière,et al.  Anatomie humaine descriptive et topographique , 1924 .